- Home
- ADMA vs SBRA Comparison
ADMA vs SBRA Comparison
Compare ADMA & SBRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- SBRA
- Stock Information
- Founded
- ADMA 2004
- SBRA 2010
- Country
- ADMA United States
- SBRA United States
- Employees
- ADMA N/A
- SBRA N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- SBRA Real Estate Investment Trusts
- Sector
- ADMA Health Care
- SBRA Real Estate
- Exchange
- ADMA Nasdaq
- SBRA Nasdaq
- Market Cap
- ADMA 3.8B
- SBRA 4.0B
- IPO Year
- ADMA N/A
- SBRA N/A
- Fundamental
- Price
- ADMA $16.90
- SBRA $16.72
- Analyst Decision
- ADMA Strong Buy
- SBRA Buy
- Analyst Count
- ADMA 4
- SBRA 6
- Target Price
- ADMA $21.25
- SBRA $19.17
- AVG Volume (30 Days)
- ADMA 2.5M
- SBRA 1.7M
- Earning Date
- ADMA 02-26-2025
- SBRA 02-19-2025
- Dividend Yield
- ADMA N/A
- SBRA 7.19%
- EPS Growth
- ADMA N/A
- SBRA N/A
- EPS
- ADMA 0.28
- SBRA 0.41
- Revenue
- ADMA $382,809,000.00
- SBRA $682,324,000.00
- Revenue This Year
- ADMA $66.90
- SBRA N/A
- Revenue Next Year
- ADMA $13.76
- SBRA $7.39
- P/E Ratio
- ADMA $60.29
- SBRA $41.07
- Revenue Growth
- ADMA 63.39
- SBRA 20.53
- 52 Week Low
- ADMA $5.02
- SBRA $12.85
- 52 Week High
- ADMA $23.64
- SBRA $20.03
- Technical
- Relative Strength Index (RSI)
- ADMA 48.60
- SBRA 45.41
- Support Level
- ADMA $15.70
- SBRA $16.45
- Resistance Level
- ADMA $16.60
- SBRA $17.05
- Average True Range (ATR)
- ADMA 0.69
- SBRA 0.41
- MACD
- ADMA 0.10
- SBRA 0.02
- Stochastic Oscillator
- ADMA 77.17
- SBRA 33.04
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About SBRA Sabra Health Care REIT Inc.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.